The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 8, 2010, Pages 824-830

  Koldamova, Radosveta ^a   Fitz, Nicholas F ^a   Lefterov, Iliya ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

ABCA1; Alzheimer's disease; Amyloid deposition; Animal model; APOE; Cell cholesterol transport; Cognitive impairment; Liver X Receptor

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CASPASE; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR;

ALZHEIMER DISEASE; BIOGENESIS; CHOLESTEROL TRANSPORT; DISULFIDE BOND; GENE DISRUPTION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LIPID OXIDATION; MOLECULAR WEIGHT; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CENTRAL NERVOUS SYSTEM; CHOLESTEROL; GENETIC VARIATION; HUMANS; NERVE DEGENERATION;

ANIMALIA;

EID: 77953258151     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.02.010     Document Type: Review

References (73)

1. Dean M., Hamon Y., and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42 7 (2001) 1007-1017
2. Luciani M.F., Denizot F., Savary S., Mattei M.G., and Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21 1 (1994) 150-159 10.1006/geno.1994.1237
3. Luciani M.F., and Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 15 2 (1996) 226-235
4. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., Freyssinet J.M., Devaux P.F., McNeish J., Marguet D., and Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2 7 (2000) 399-406 10.1038/35017029
5. Santamarina-Fojo S., Peterson K., Knapper C., Qiu Y., Freeman L., Cheng J.F., Osorio J., Remaley A., Yang X.P., Haudenschild C., Prades C., Chimini G., Blackmon E., Francois T., Duverger N., Rubin E.M., Rosier M., Denèfle P., Fredrickson D.S., and Brewer Jr. H.B. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci. U. S. A. 97 14 (2000) 7987-7992
6. Oram J.F., and Lawn R.M. ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 42 8 (2001) 1173-1179
7. Bodzioch M., Orsó E., Klucken J., Langmann T., Böttcher A., Diederich W., Drobnik W., Barlage S., Büchler C., Porsch-Ozcürümez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 4 (1999) 347-351 10.1038/11914
8. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest Jr. J., and Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 4 (1999) 336-345 10.1038/11905
9. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denèfle P., and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 4 (1999) 352-355 10.1038/11921
10. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., and Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 5484 (2000) 1524-1529
11. Denis M., Haidar B., Marcil M., Bouvier M., Krimbou L., and Genest J. Characterization of oligomeric human atp binding cassette transporter a1. Potential implications for determining the structure of nascent high density lipoprotein particles. J. Biol. Chem. 279 40 (2004) 41529-41536 10.1074/jbc.M406881200
12. Trompier D., Alibert M., Davanture S., Hamon Y., Pierres M., and Chimini G. Transition from dimers to higher oligomeric forms occurs during the atpase cycle of the ABCA1 transporter. J. Biol. Chem. 281 29 (2006) 20283-20290 10.1074/jbc.M601072200
13. Vedhachalam C., Ghering A.B., Davidson W.S., Lund-Katz S., Rothblat G.H., and Phillips M.C. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler. Thromb. Vasc. Biol. 27 7 (2007) 1603-1609 10.1161/ATVBAHA.107.145789
14. Vedhachalam C., Duong P.T., Nickel M., Nguyen D., Dhanasekaran P., Saito H., Rothblat G.H., Lund-Katz S., and Phillips M.C. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem. 282 34 (2007) 25123-25130 10.1074/jbc.M704590200
15. Yvan-Charvet L., Wang N., and Tall A.R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 30 2 (2010) 139-143 10.1161/ATVBAHA.108.179283
16. Ho Hong S., Rhyne J., Zeller K., and Miller M. Novel ABCA1 compound variant associated with HDL cholesterol deficiency cholesterol deficiency. Biochim. Biophys. Acta 1587 1 (2002) 60-64
17. Koldamova R.P., Lefterov I.M., Staufenbiel M., Wolfe D., Huang S., Glorioso J.C., Walter M., Roth M.G., and Lazo J.S. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 280 6 (2005) 4079-4088 10.1074/jbc.M411420200
18. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., and Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 8 (1993) 1467-1472
19. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 5123 (1993) 921-923
20. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 8873 (1993) 697-699
21. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O., Roomp K., Jukema J.W., van Wijland M., van Dam M., Hudson T.J., Brooks-Wilson A., Genest Jr. J., Kastelein J.J., and Hayden M.R. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 9 (2001) 1198-1205
22. Li Y., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Lau K., Catanese J., Sninsky J., Nowotny P., Holmans P., Hardy J., Powell J., Lovestone S., Thal L., Owen M., Williams J., Goate A., and Grupe A. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci. Lett. 366 3 (2004) 268-271 10.1016/j.neulet.2004.05.047
23. Wollmer M.A., Streffer J.R., Lütjohann D., Tsolaki M., Iakovidou V., Hegi T., Pasch T., and Jung H.H. K. v. Bergmann, R. M. Nitsch, C. Hock, A. Papassotiropoulos, ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 24 3 (2003) 421-426
24. Shibata N., Kawarai T., Lee J.H., Lee H.-S., Shibata E., Sato C., Liang Y., Duara R., Mayeux R.P., St George-Hyslop P.H., and Rogaeva E. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci. Lett. 391 3 (2006) 142-146 10.1016/j.neulet.2005.08.048
25. Wahrle S.E., Shah A.R., Fagan A.M., Smemo S., Kauwe J.S.K., Grupe A., Hinrichs A., Mayo K., Jiang H., Thal L.J., Goate A.M., and Holtzman D.M. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol. Neurodegener. 2 (2007) 7 10.1186/1750-1326-2-7
26. Chu L.W., Li Y., Li Z., Tang A.Y.B., Cheung B.M.Y., Leung R.Y.H., Yik P.-Y., Jin D.-Y., and Song Y.-Q. A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B 8 (2007) 1007-1013 10.1002/ajmg.b.30525
27. Bertram L., Hiltunen M., Parkinson M., Ingelsson M., Lange C., Ramasamy K., Mullin K., Menon R., Sampson A.J., Hsiao M.Y., Elliott K.J., Velicelebi G., Moscarillo T., Hyman B.T., Wagner S.L., Becker K.D., Blacker D., and Tanzi R.E. Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 352 9 (2005) 884-894 10.1056/NEJMoa042765
28. Katzov H., Chalmers K., Palmgren J., Andreasen N., Johansson B., Cairns N.J., Gatz M., Wilcock G.K., Love S., Pedersen N.L., Brookes A.J., Blennow K., Kehoe P.G., and Prince J.A. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum. Mutat. 23 4 (2004) 358-367 10.1002/humu.20012
29. Reynolds C.A., Hong M.-G., Eriksson U.K., Blennow K., Bennet A.M., Johansson B., Malmberg B., Berg S., Wiklund F., Gatz M., Pedersen N.L., and Prince J.A. A survey of ABCA1 sequence variation confirms association with dementia. Hum. Mutat. 30 9 (2009) 1348-1354 10.1002/humu.21076
30. Wang F., and Jia J. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res. 1147 1 (2007) 34-38 cited by (since 1996) 9. (URL http://www.scopus.com/inward/record.url?eid=2-s2.0-3414 7158749&partnerID=40
31. Wavrant-De Vrièze F., Compton D., Womick M., Arepalli S., Adighibe O., Li L., Pérez-Tur J., and Hardy J. ABCA1 polymorphisms and Alzheimer's disease. Neurosci. Lett. 416 2 (2007) 180-183 10.1016/j.neulet.2007.02.010
32. Rodríguez-Rodríguez E., Mateo I., Llorca J., Sánchez-Quintana C., Infante J., García-Gorostiaga I., Sánchez-Juan P., Berciano J., and Combarros O. Association of genetic variants of ABCA1 with Alzheimer's disease risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B 7 (2007) 964-968 10.1002/ajmg.b.30552
33. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schürmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Hüll M., Rujescu D., Goate A.M., Kauwe J.S.K., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.-H., Klopp N., Wichmann H.-E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., and Williams J. Genome-wide association study identifies variants at clu and picalm associated with Alzheimer's disease. Nat. Genet. 41 10 (2009) 1088-1093 10.1038/ng.440
34. Lambert J.-C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., European Alzheimer's Disease Initiative Investigators, de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.-F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., and Amouyel P. Genome-wide association study identifies variants at clu and cr1 associated with Alzheimer's disease. Nat. Genet. 41 10 (2009) 1094-1099 10.1038/ng.439
35. Walter M., Kerber S., Fechtrup C., Seedorf U., Breithardt G., and Assmann G. Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency. Atherosclerosis 110 2 (1994) 203-208
36. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 5685 (2004) 869-872 10.1126/science.1099870
37. Iatan I., Alrasadi K., Ruel I., Alwaili K., and Genest J. Effect of ABCA1 mutations on risk for myocardial infarction. Curr. Atheroscler. Rep. 10 5 (2008) 413-426
38. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., and Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257 1 (1999) 29-33 10.1006/bbrc.1999.0406
39. Lawn R.M., Wade D.P., Couse T.L., and Wilcox J.N. Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues. Arterioscler. Thromb. Vasc. Biol. 21 3 (2001) 378-385
40. Whitney K.D., Watson M.A., Collins J.L., Benson W.G., Stone T.M., Numerick M.J., Tippin T.K., Wilson J.G., Winegar D.A., and Kliewer S.A. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16 6 (2002) 1378-1385
41. Fukumoto H., Deng A., Irizarry M.C., Fitzgerald M.L., and Rebeck G.W. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J. Biol. Chem. 277 50 (2002) 48508-48513 10.1074/jbc.M209085200
42. Koldamova R.P., Lefterov I.M., Ikonomovic M.D., Skoko J., Lefterov P.I., Isanski B.A., DeKosky S.T., and Lazo J.S. 22r-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278 15 (2003) 13244-13256 10.1074/jbc.M300044200
43. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., Kowalewski T., and Holtzman D.M. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279 39 (2004) 40987-40993 10.1074/jbc.M407963200
44. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., and Wellington C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279 39 (2004) 41197-41207 10.1074/jbc.M407962200
45. Kim W.S., Rahmanto A.S., Kamili A., Rye K.-A., Guillemin G.J., Gelissen I.C., Jessup W., Hill A.F., and Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J. Biol. Chem. 282 5 (2007) 2851-2861 10.1074/jbc.M607831200
46. Ikonomovic M., Abrahamson E., Koldamova R., Lefterov I., Isanski B., Lazo J., and DeKosky S. Changes in brain cholesterol transporter ABCA1 following controlled cortical injury in rats. J. Neurotrauma 20 10 (2003) P359
47. Brown III J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 33 (2004) 34674-34681 10.1074/jbc.M402324200
48. Sun Y., Yao J., Kim T.-W., and Tall A.R. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J. Biol. Chem. 278 30 (2003) 27688-27694 10.1074/jbc.M300760200
49. Burns M.P., Vardanian L., Pajoohesh-Ganji A., Wang L., Cooper M., Harris D.C., Duff K., and Rebeck G.W. The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo. J Neurochem 98 3 (2006) 792-800 10.1111/j.1471-4159.2006.03925.x
50. Lefterov I., Bookout A., Wang Z., Staufenbiel M., Mangelsdorf D., and Koldamova R. Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment. Mol. Neurodegener. 2 (2007) 20 10.1186/1750-1326-2-20
51. Riddell D.R., Zhou H., Comery T.A., Kouranova E., Lo C.F., Warwick H.K., Ring R.H., Kirksey Y., Aschmies S., Xu J., Kubek K., Hirst W.D., Gonzales C., Chen Y., Murphy E., Leonard S., Vasylyev D., Oganesian A., Martone R.L., Pangalos M.N., Reinhart P.H., and Jacobsen J.S. The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Neurosci. 34 4 (2007) 621-628 10.1016/j.mcn.2007.01.011
52. Jiang Q., Lee C.Y.D., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T.M., Collins J.L., Richardson J.C., Smith J.D., Comery T.A., Riddell D., Holtzman D.M., Tontonoz P., and Landreth G.E. ApoE promotes the proteolytic degradation of Aβ. Neuron 58 5 (2008) 681-693 10.1016/j.neuron.2008.04.010
53. Karasinska J.M., Rinninger F., Lütjohann D., Ruddle P., Franciosi S., Kruit J.K., Singaraja R.R., Hirsch-Reinshagen V., Fan J., Brunham L.R., Bissada N., Ramakrishnan R., Wellington C.L., Parks J.S., and Hayden M.R. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29 11 (2009) 3579-3589 10.1523/JNEUROSCI.4741-08.2009
54. Koldamova R.P., Lefterov I.M., Lefterova M.I., and Lazo J.S. Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A-beta aggregation and toxicity. Biochemistry 40 12 (2001) 3553-3560
55. Balazs Z., Panzenboeck U., Hammer A., Sovic A., Quehenberger O., Malle E., and Sattler W. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J. Neurochem. 89 4 (2004) 939-950 10.1111/j.1471-4159.2004.02373.x
56. Panzenboeck U., Balazs Z., Sovic A., Hrzenjak A., Levak-Frank S., Wintersperger A., Malle E., and Sattler W. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J. Biol. Chem. 277 45 (2002) 42781-42789 10.1074/jbc.M207601200
57. Hong S.H., Riley W., Rhyne J., Friel G., and Miller M. Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, g2265t. Clin. Chem. 48 11 (2002) 2066-2070
58. Wahrle S.E., Jiang H., Parsadanian M., Kim J., Li A., Knoten A., Jain S., Hirsch-Reinshagen V., Wellington C.L., Bales K.R., Paul S.M., and Holtzman D.M. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118 2 (2008) 671-682 10.1172/JCI33622
59. I. Lefterov, N. F. Fitz, A. Cronican, P. Lefterov, M. Staufenbiel, R. Koldamova, Memory deficits in APP23/Abca1+/- mice correlate with the level of Aβ oligomers, ASN Neuro 1 (2). doi:10.1042/AN20090015
60. Miao J., Vitek M.P., Xu F., Previti M.L., Davis J., and Van Nostrand W.E. Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice. J. Neurosci. 25 27 (2005) 6271-6277 10.1523/JNEUROSCI.1306-05.2005
61. Pfrieger F.W., and Barres B.A. Synaptic efficacy enhanced by glial cells in vitro. Science 277 5332 (1997) 1684-1687
62. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 5545 (2001) 1354-1357 10.1126/science.294.5545.1354
63. Zelcer N., Khanlou N., Clare R., Jiang Q., Reed-Geaghan E.G., Landreth G.E., Vinters H.V., and Tontonoz P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. U. S. A. 104 25 (2007) 10601-10606 10.1073/pnas.0701096104
64. Cronican A.A., Fitz N.F., Pham T.., Fogg A., Kifer B., Koldamova R., and Lefterov I. Proton pump inhibitor Lansoprazole is a nuclear liver X receptor agonist. Biochem. Pharmacol. 79 9 (2010) 1310-1316 10.1016/j.bcp.2009.12.018
65. Suzuki S., Nishimaki-Mogami T., Tamehiro N., Inoue K., Arakawa R., Abe-Dohmae S., Tanaka A.R., Ueda K., and Yokoyama S. Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler. Thromb. Vasc. Biol. 24 3 (2004) 519-525 10.1161/01.ATV.0000117178.94087.ba
66. Wang N., and Tall A.R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 7 (2003) 1178-1184 10.1161/01.ATV.0000075912.83860.26
67. Wang N., Chen W., Linsel-Nitschke P., Martinez L.O., Agerholm-Larsen B., Silver D.L., and Tall A.R. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111 1 (2003) 99-107 10.1172/JCI16808
68. Chen W., Wang N., and Tall A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J. Biol. Chem. 280 32 (2005) 29277-29281 10.1074/jbc.M505566200
69. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., and Tall A.R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278 39 (2003) 37368-37374 10.1074/jbc.M307161200
70. Feng B., and Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem. 277 45 (2002) 43271-43280 10.1074/jbc.M207532200
71. Park S.K., and Prolla T.A. Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res. Rev. 4 1 (2005) 55-65 cited by (since 1996): 32
72. Panzenboeck U., Kratzer I., Sovic A., Wintersperger A., Bernhart E., Hammer A., Malle E., and Sattler W. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. Int. J. Biochem. Cell Biol. 38 8 (2006) 1314-1329 10.1016/j.biocel.2006.01.013
73. Gosselet F., Candela P., Sevin E., Berezowski V., Cecchelli R., and Fenart L. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res. 1249 (2009) 34-42 10.1016/j.brainres.2008.10.036